CDC says JN.1 variant accounts for about 86% of COVID cases in US

CDC says JN.1 variant accounts for about 86% of COVID cases in US

/ 11:12 AM January 23, 2024

COVID JN.1 variant

Travelers board an Amtrak train at Union Station on November 22, 2023 in Washington, DC. AFP FILE PHOTO

The US Centers for Disease Control and Prevention (CDC) on Monday estimated COVID subvariant JN.1 to account for about 85.7% of cases in the United States, as of Jan. 19.

The agency said JN.1 remains the most widely circulating variant of SARS-CoV-2 in the country and globally.

Article continues after this advertisement

There is no evidence at present that JN.1 causes more severe disease than other variants, the CDC said, adding that currently available vaccines are expected to increase protection against the variant.

FEATURED STORIES

READ: JN.1 variant accounts for 39%-50% of Covid cases in US

JN.1, which traces its lineage back to BA.2.86, was classified a “variant of interest” by the World Health Organization in December.

Article continues after this advertisement

The predicted range of 83% to 88% marks an increase from the estimated prevalence of 55% to 68% of cases in the U.S., as per the agency’s projections from Jan. 5.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Health, US CDC

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.